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Abstract	  
The	  aim	  of	  this	  study	  was	  the	  development	  of	  gag	  and	  pol	  dual	   labelled	  probe	  real-­‐time	  PCR	  and	  RT	  PCR	  
assays	  to	  quantify	  the	  proviral	  load	  and	  the	  transcripts	  of	  the	  British	  Visna/maedi	  virus	  EV1	  strain.	  Primers	  
and	  probes	  were	  chosen	  based	  on	   the	  consensus	  sequences	  of	  gag	  and	  pol	  clones	   representative	  of	  EV1	  
genetic	  variants.	  Both	  PCRs	  had	  a	  detection	  limit	  of	  3	  copies	  of	  target	  gene,	  with	  a	  linearity	  over	  6	  orders	  of	  
magnitude.	  The	  performances	  of	  the	  two	  PCRs	   in	  vivo	  were	  evaluated	  and	  compared	  on	  a	  panel	  of	  DNAs	  
extracted	   from	   blood	   of	   sheep	   infected	   experimentally	   with	   EV1.	   The	   pol	   assay	   detected	   in	  most	   cases	  
lower	  numbers	  of	  viral	  molecules	  than	  gag	  assay,	  yielding	  some	  false	  negative	  results.	  The	  gag	  real-­‐time	  RT	  
PCR	  had	  a	  detection	   limit	  of	  100	  RNA	  molecules	  with	  a	   linearity	  over	  5	  orders	  of	  magnitude.	  This	  did	  not	  
result	  in	  a	  lower	  performance	  of	  the	  RT	  PCR	  compared	  to	  the	  PCR	  in	  cells	  permissive	  for	  virus	  replication,	  
which	  contain	  higher	  numbers	  of	  viral	  transcripts	  than	  proviral	  genomes.	  The	  real-­‐time	  assays	  developed	  in	  
this	  study,	  particularly	  the	  gag	  assay,	  provide	  a	  sensitive	  tool	  which	  can	  be	  used	  to	  quantify	  the	  viral	  load	  in	  
experimental	  infections.	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1.	  Introduction	  
The	  ovine	   LentivirusVisna/maedi	   virus	   (VMV)	   is	   the	   causative	  agent	  of	  a	   chronic	   inflammatory	  disease	  of	  
sheep	   affecting	   primarily	   lungs,	   central	   nervous	   system,	  mammary	   glands	   and	   joints.	   VMV	  was	   the	   first	  
lentivirus	  to	  be	   isolated	  (	  Gudnadottir	  and	  Palsson,	  1967	  and	  Sigurdsson,	  1954).	  Since	  then,	  several	  other	  
members	   of	   this	   genus	   of	   the	   family	   Retroviridae	   have	   been	   identified,	   including	   caprine	   arthritis	  
encephalitis	   virus	   (CAEV),	   equine	   infectious	   anemia	   virus	   (EIAV)	   and	   human,	   simian,	   feline	   and	   bovine	  
immunodeficiency	  viruses	  (HIV,	  SIV,	  FIV	  and	  BIV	  respectively).	  VMV	  has	  long	  been	  considered	  the	  prototype	  
lentivirus	   (	   Carey	   and	  Dalziel,	   1993	   and	  Narayan	   and	  Clements,	   1989)	   and	  has	   been	  widely	   employed	   to	  
study	  many	   aspects	   of	   lentiviral	   infections,	   such	   as	   the	  molecular	  mechanisms	  underlying	   viral	   tropism	   (	  
Agnarsdóttir	  et	  al.,	  2000,	  Barros	  et	  al.,	  2005,	  Chebloune	  et	  al.,	  1996	  and	  Óskarsson	  et	  al.,	  2007),	  persistence	  
and	  pathogenesis	   (	   Torsteinsdottir	   et	   al.,	   2007),	   routes	  of	   viral	   transmission	   (	  Blacklaws	  et	   al.,	   2004)	  and	  
strategies	  to	  eradicate	  or	  prevent	  the	  infection	  (	  de	  Andres	  et	  al.,	  2005	  and	  Reina	  et	  al.,	  2009).	  The	  British	  
VMV	   strain	   EV1	   was	   isolated	   from	   a	   sheep	   displaying	   symptoms	   of	   arthritis	   and	   pneumonia	   and	   its	  
complete	  genome	  was	  cloned	  and	  sequenced	   (	  Sargan	  et	  al.,	  1991).	  This	   strain	  has	  been	  and	   is	  currently	  
used	  for	  in	  vivo	  and	  in	  vitro	  studies	  focusing	  on	  diverse	  topics	  such	  as	  the	  identification	  of	  viral	  promoter	  
elements,	  or	  cytokines	  that	  control	  the	  expression	  and	  replication	  of	  the	  virus	  (	  Sargan	  et	  al.,	  1995,	  Sutton	  
et	  al.,	   1997	  and	  Zhang	  et	  al.,	   2002),	   the	  dissection	  of	   the	   initial	   steps	  of	   the	   infection	   (	  Bird	  et	  al.,	   1993,	  
Blacklaws	  et	  al.,	  1995	  and	  Ryan	  et	  al.,	  2000),	  the	  characterization	  of	  the	  immune	  response	  (	  Bird	  et	  al.,	  1993	  
and	  Singh	  et	  al.,	  2006),	  the	  routes	  of	  viral	  entry	  and	  dissemination	  (	  Blacklaws	  et	  al.,	  1995,	  McNeilly	  et	  al.,	  
2007	   and	  Niesalla	   et	   al.,	   2008)	   and	   the	   development	   of	   immunization	   strategies	   (	   Gonzalez	   et	   al.,	   2005,	  
Niesalla	  et	  al.,	  2009	  and	  Reina	  et	  al.,	  2008).	  In	  some	  of	  these	  studies	  the	  presence	  of	  the	  EV1	  genome	  has	  
been	  investigated	  by	  conventional	  PCR	  (	  Bird	  et	  al.,	  1993,	  Niesalla	  et	  al.,	  2008	  and	  Ryan	  et	  al.,	  2000)	  or	  by	  
quantitative	  competitive	  PCR	  (QC	  PCR)	  (	  Zhang	  et	  al.,	  2000).	  The	  aim	  of	  this	  work	  was	  the	  development	  of	  a	  
highly	  sensitive	  dual	  labelled	  probe	  real-­‐time	  PCR	  for	  the	  absolute	  quantitation	  of	  EV1	  viral	  load	  in	  vivo	  and	  
in	   vitro.	   Two	  viral	   genes,	   gag	  and	  pol,	  were	   chosen	  as	   targets	   for	   amplification	  and	  DNA	  and	  RNA	  based	  
real-­‐time	  PCR	  assays	  were	  developed	  and	  evaluated.	  
2.	  Materials	  and	  methods	  
2.1.	  Viral	  strain	  
A	   low	  passage	  viral	  stock	  of	  VMV	  strain	  EV1	  (5th	  passage,	  3.6	  ×	  106	  TCID50/ml)	  was	  grown	  and	  titred	  as	  
described	  previously	  (Bird	  et	  al.,	  1993	  and	  Sargan	  et	  al.,	  1991).	  
2.2.	  Cloning	  and	  sequencing	  of	  EV1	  gag	  and	  pol	  gene	  fragments	  
Primary	  lung	  fibroblasts	  were	  infected	  with	  EV1	  at	  a	  m.o.i.	  of	  0.4	  TCID50/cell.	  Two	  days	  later	  genomic	  DNA	  
was	   extracted	   (DNeasy	   Tissue	   Kit,	   Qiagen,	   Hilden,	   Germany)	   and	   the	   presence	   of	   EV1	   provirus	   was	  
confirmed	  by	  nested	  pol	  PCR	  (	  Zhang	  et	  al.,	  2000).	  
	  
A	  567	  bp	  gag	  and	  a	  492	  bp	  pol	   fragment	  were	  amplified	  with	  proof	   reading	  DNA	  polymerase	   (Proofstart	  
DNA	  Polymerase,	  Qiagen,	  Hilden,	  Germany).	   The	  primers	   (	   Table	  1)	  were	  designed	  on	   the	  published	  EV1	  
sequence	   (	   Sargan	  et	   al.,	   1991)	  using	  Primer	  3	   (	  Rozen	  and	  Skaletsky,	   2000).	  Amplicons	  were	  A	   tailed	   (A	  
Addition	   Kit,	   Qiagen,	   Hilden,	   Germany)	   and	   cloned	   in	   pDRIVE	   cloning	   vector	   (PCR	   Cloning	   Kit,	   Qiagen,	  
Hilden,	   Germany).	   Eleven	   gag	   and	   eleven	   pol	   plasmid	   clones	   were	   sequenced	   on	   both	   strands	   (Thermo	  
Sequenase	   Cy5	   Dye	   Terminator	   Cycle	   Sequencing	   kit,	   Amersham	   Biosciences,	   Little	   Chalfont,	   UK).	  
Consensus	  sequences	  (	  Fig.	  1A	  and	  B)	  were	  generated	  with	  Bioedit	  Sequence	  Alignment	  Editor	  (	  Hall,	  1999).	  
	  
	  	  	  	  Table	  1.	  
	  
	  	  	  	  	  Fig.	  1.	  	  
	  	  	  	  EV1	  real-­‐time	  amplicon	  sequences:	  A:	  gag	  amplicon;	  B:	  pol	  amplicon.	  Alignment	  of	  11	  clones	  with	  consensus	  and	  with	  EV1	  sequence	  (GenBank	  
accession	  no.	  S51392).	  Underlined	  bold	   indicates	  real-­‐time	  primers	  and	  probe	  positions.	  Conserved	  nucleotides	  are	  depicted	  as	  dots,	  nucleotides	  
that	  differ	  from	  the	  consensus	  are	  shown.	  
2.3.	  Primers	  and	  dual	  labelled	  probes	  
Beacon	  Designer	   software	   v2.0	   (Premier	   Biosoft	   International,	   Palo	  Alto,	   CA)	  was	   used	   to	   design	   several	  
primer	   and	   probe	   sets	   within	   the	   consensus	   sequence	   of	   gag	   and	   pol	   clones.	   Primer	   and	   probe	  
combinations	   to	   be	   used	   in	   real-­‐time	   assays	  were	   further	   selected	   based	   on	   the	   homology	  with	   variant	  
sequences	   (	  Table	  1,	  Fig.	  1A	  and	  B).	  The	  5ʹ′	  and	  3ʹ′	  end	  of	   the	  probes	  (Operon,	  Ebersberg,	  Germany)	  were	  
labeled	   with	   reporter	   6	   Carboxyfluorescein	   (6	   FAM)	   and	   quencher	   Black	   Hole	   Quencher	   1a	   (BHQ	   1a)	  
respectively.	  The	  ability	  of	  the	  selected	  primers	  to	  amplify	  viral	  DNA	  was	  evaluated	  by	  conventional	  PCR	  on	  
plasmid	  clones	  representative	  of	  consensus	  and	  variant	  viral	  sequences.	  
2.4.	  DNA	  standards	  
Serial	  dilutions	  of	  gag	  and	  pol	  consensus	  clones	  (clone	  3	  for	  both	  genes,	  Fig.	  1A	  and	  B),	  corresponding	  to	  1	  ×	  
106,	  1	  ×	  104,	  1	  ×	  103,	  1	  ×	  102,	  60,	  30,	  10,	  6,	  and	  3	  molecules	  per	  reaction	  were	  used	  to	  generate	  standard	  
curves.	   To	  determine	  whether	   the	  presence	  of	  background	  nucleic	   acid	  would	  affect	   assay	  performance,	  
two	   series	  of	   reactions	  were	   repeatedly	   carried	  out	   in	  parallel:	   in	   one,	   pure	  plasmid	  DNA	  dilutions	  were	  
used	  as	  template,	   in	   the	  other,	  plasmid	  DNA	  was	  spiked	  with	  500	  ng	  of	  VMV	  free	  ovine	  genomic	  DNA	  to	  
mimic	  the	  biological	  samples.	  
2.5.	  Gag	  real-­‐time	  PCR	  assay	  
The	   assay	   was	   set	   up	   using	   dilutions	   of	   consensus	   plasmid	   clone	   3	   (Fig.	   1A)	   as	   template.	   Plasmid	   was	  
linearized,	   the	   DNA	   concentration	  was	  measured	  with	   PicoGreen	   dsDNA	   Assay	   Kit	   (Invitrogen,	   Carlsbad,	  
CA),	   the	   number	   of	   molecules	   per	   microliter	   was	   calculated	   and	   the	   dilution	   series	   (2	   ×	   105	   to	   1	  
molecule/μl)	  prepared	  accordingly.	  The	  real-­‐time	  reactions	  were	  carried	  out	  with	  the	  Quantitect	  Probe	  PCR	  
Kit	  (Qiagen,	  Hilden,	  Germany),	  using	  an	  iCycler	  Real-­‐Time	  PCR	  Detection	  System	  (Biorad,	  Hercules,	  CA).	  All	  
reactions	  were	  carried	  out	  in	  triplicate,	  in	  a	  volume	  of	  25	  μl,	  with	  5	  μl	  of	  template.	  Primers	  and	  probe	  were	  
used	  at	  a	  concentration	  of	  1	  μM	  and	  0.2	  μM	  respectively.	  The	  amplification	  programme	  was:	  15	  min	  at	  95	  
°C,	  followed	  by	  50	  cycles	  of	  15	  s	  at	  94	  °C	  and	  1	  min	  at	  58	  °C.	  No	  template	  reactions	  and	  DNA	  from	  VMV	  free	  
ovine	  lung	  fibroblast	  cell	  culture	  were	  used	  as	  negative	  controls.	  
2.5.1.	  Gag	  assay	  performance	  on	  viral	  variants	  
The	  assay	  was	  performed	  using	  as	  template	  a	  dilution	  series	  of	  plasmids	  carrying	  either	  consensus	  (clones	  3	  
and	   11)	   or	   variant	   (clones	   1	   and	   6)	   primer	   and	   probe	   sequences	   (Fig.	   1A).	   Dilutions	   and	   reactions	  were	  
carried	  out	  as	  described	  above.	  
2.5.2.	  Gag	  real-­‐time	  RT	  PCR	  assay	  
A	  one	  step	  assay	  was	  developed	  for	  the	  absolute	  quantitation	  of	  viral	  RNA,	  with	  the	  same	  gag	  primers	  and	  
probe	  used	  for	  the	  DNA	  based	  PCR.	  The	  assay	  was	  performed	  in	  triplicate	  with	  the	  Quantitect	  Probe	  RT	  PCR	  
Kit	  (Qiagen,	  Hilden,	  Germany),	  with	  1	  μl	  of	  template	  in	  a	  volume	  of	  20	  μl.	  Primers	  and	  probe	  were	  used	  at	  a	  
concentration	  of	  1.0	  μM	  and	  0.2	  μM	  respectively.	  The	  amplification	  programme	  was:	  30	  min	  at	  50	  °C	  for	  
reverse	  transcription,	  followed	  by	  15	  min	  at	  95	  °C	  then	  50	  cycles	  of	  15	  s	  at	  94	  °C	  and	  1	  min	  at	  58	  °C.	  
2.5.3.	  Gag	  RNA	  standard	  
Gag	   plasmid	   clone	   3	   was	   linearized	   downstream	   of	   the	   insert	   with	   BamHI	   and	   used	   as	   template	   in	   a	  
transcription	  reaction	  driven	  by	  the	  SP6	  promoter	  of	  pDRIVE	  (MAXIscript	  SP6/T7	  In	  Vitro	  Transcription	  Kit,	  
Ambion,	   Austin,	   TX,	   USA).	   Following	   plasmid	   DNA	   removal	   by	   RNase	   free	   DNase	   treatment	   (RNase	   Free	  
DNase	   Set,	   Qiagen,	   Hilden,	   Germany),	   the	   transcript	   was	   purified	   and	   concentrated	   with	   the	   RNeasy	  
Minelute	   Cleanup	   Kit	   (Qiagen,	   Hilden,	   Germany)	   and	   quantified	   with	   the	   RiboGreen	   RNA	   Quantitation	  
Reagent	  and	  Kit	  (Invitrogen,	  Carlsbad,	  CA).	  The	  number	  of	  RNA	  molecules/μl	  was	  calculated	  and	  a	  dilution	  
series	  was	  prepared	  (1	  ×	  106	  to	  10	  copies/μl).	  
2.5.4.	  Gag	  real-­‐time	  vs.	  GAG	  real-­‐time	  RT	  PCR	  assay	  performance	  
DNA	   and	   RNA	   were	   extracted	   (Dneasy	   Tissue	   Kit	   and	   RNeasy	   Mini	   Kit,	   Qiagen,	   Hilden,	   Germany)	   from	  
aliquots	   of	   the	   same	   EV1	   infected	   ovine	   fibroblast	   cell	   culture	   2	   days	   post-­‐infection	   (p.i.)	   (m.o.i.	   of	   0.4	  
TCID50/cell).	  Following	  fluorometric	  quantitation,	  serially	  diluted	  DNA	  (140	  ng/l	  to	  0.14	  pg/l)	  and	  RNA	  (100	  
ng/l	  to	  0.1	  pg/l)	  were	  amplified	  by	  real-­‐time	  PCR	  and	  real-­‐time	  RT	  PCR	  respectively.	  Each	  sample	  was	  tested	  
in	  triplicate.	  The	  results	  were	  expressed	  as	  viral	  copy	  numbers	  per	  microgram	  of	  DNA	  and	  RNA	  respectively.	  
2.6.	  Pol	  LUX	  PCR	  assay	  
An	   assay	   was	   developed	   with	   fluorogenic	   LUX	   primers	   (Invitrogen,	   Carlsbad,	   CA),	   selected	   with	   LUX	  
Designer	   software	   (Invitrogen,	   Carlsbad,	   CA)	   within	   the	   consensus	   sequence	   of	   pol	   clones.	   Primer	  
sequences	  are	  shown	   in	  Table	  1.	  Reactions	  were	  carried	  out	   in	   triplicate	  on	  serial	  dilutions	   (2	  ×	  105	   to	  1	  
molecule/μl)	   of	   pol	   consensus	   clone	   3,	   with	   5	   μl	   of	   template	   in	   25	   μl	   reaction	   volume	   (Platinum	  
Quantitative	  PCR	  SuperMix	  UDG,	  Invitrogen,	  Carlsbad,	  CA).	  The	  amplification	  programme	  was:	  2	  min	  at	  50	  
°C,	  2	  min	  at	  95	  °C,	  followed	  by	  45	  cycles	  of	  15	  s	  at	  95	  °C,	  30	  s	  at	  55	  °C	  and	  30	  s	  at	  72	  °C.	  
2.7.	  Pol	  dual	  labelled	  probe	  real-­‐time	  PCR	  assay	  
The	   dual	   labelled	   probe	   real-­‐time	   assay	   was	   set	   up	   as	   described	   for	   gag,	   except	   that	   the	   annealing	  
temperature	  was	  56	  °C.	  
2.8.	  Evaluation	  of	  specificity	  and	  sensitivity	  of	  gag	  and	  pol	  dual	  labelled	  probe	  PCR	  assays:	  analysis	  of	  blood	  
samples	  
Both	  dual	   labelled	  probe	  real-­‐time	  PCR	  assays	  were	  used	  to	  analyze	  a	  panel	  of	  204	  DNAs	  extracted	   from	  
peripheral	  blood	  mononuclear	  cells	   (PBMCs)	  of	  68	  sheep	   infected	  experimentally	  with	  the	  EV1	  viral	  stock	  
described	  above,	  sampled	  at	   increasing	   time	   intervals	  until	  3	  months	  p.i.	  Previous	   identification	  of	  sheep	  
infected	  successfully	  was	  based	  on	  the	  measurement	  of	  anti-­‐VMV	  antibodies	  in	  serum,	  T	  cell	  proliferation	  
and	   anti-­‐VMV	   T	   cell	   reactivity	   and	   determination	   of	   histopathological	   changes	   in	   lungs	   and	   mediastinal	  
lymph	  nodes.	  A	  total	  of	  222	  DNAs	  from	  PBMCs	  of	  74	  uninfected	  sheep	  were	  used	  as	  negative	  controls	  to	  
determine	  the	  specificity	  of	  the	  real-­‐time	  assays	  (Niesalla	  et	  al.,	  2009).	  
3.	  Results	  
3.1.	  Gag	  real-­‐time	  primers	  and	  probe	  
The	  consensus	  sequence	  of	  11	  gag	  clones	  amplified	   from	  fibroblasts	   infected	  with	  EV1	  viral	   stock	  shared	  
94%	   identity	  with	   the	  published	  EV1	  sequence.	  Real-­‐time	  primers	  and	  probe	   (	  Table	  1)	  were	  designed	   in	  
regions	   that	   displayed	   limited	   interclonal	   sequence	  heterogeneity	   (	   Fig.	   1A):	   two	   clones	   carried	   a	  G	   to	  A	  
transition	  at	  ntd	  1339	  and	  four	  at	  ntd	  1345,	  in	  both	  cases	  within	  the	  reverse	  primer.	  Three	  clones	  carried	  an	  
A	   to	   C	   transversion	   at	   ntd	   1309,	  within	   the	   probe	   sequence.	   Amplicon	   length	  was	   106	   bp.	   The	   selected	  
primers	   were	   able	   to	   amplify	   by	   conventional	   PCR	   plasmid	   clones	   carrying	   the	   variant	   viral	   sequences	  
identified	  within	  the	  EV1	  stock	  (data	  not	  shown).	  
3.1.1.	  Linear	  range	  of	  amplification	  of	  gag	  real-­‐time	  PCR	  assay	  
The	   linear	   range	  of	   amplification	  was	  determined	  over	  1	  ×	  106	   to	  3	   copies	  per	   reaction	  using	   consensus	  
plasmid	   clone	  3	  dilutions.	   The	  amplification	  of	   the	   standard	  dilutions	   showed	   linearity	  over	   six	   orders	  of	  
magnitude	   (Fig.	   2A).	   The	   assay	   was	   able	   to	   amplify	   at	   least	   one	   replica	   sample	   of	   one	   of	   the	   low	   copy	  
standards	  (6	  and	  3	  copies	  per	  reaction).	  Assay	  performance	  was	  not	  modified	  by	  spiking	  plasmid	  dilutions	  
with	  ovine	  DNA	  (data	  not	  shown).	  
	  	  	  	  	  Fig.	  2.	  	  
	  	  	  	  Linearity	  of	  the	  gag	  real-­‐time	  PCR	  assay	  and	  RT	  PCR	  assay.	   (A)	  PCR	  assay	  standard	  curve:	  the	  standard	  curve	  was	  derived	  from	  the	   logarithmic	  
input	  template	  quantity	  (copies	  per	  reaction)	  of	  consensus	  clone	  3	  (○)	  vs.	  the	  measured	  threshold	  cycle.	  Correlation	  coefficient	  of	  the	  curve	  1.000,	  
slope	  −3.607.	  The	  position	  of	  the	  Ct	  values	  for	  variant	  clone	  1	  (▵)	  and	  6	  (×)	  are	  shown.	  The	  input	  template	  copy	  number	  of	  clone	  1	  and	  6	  were	  the	  
same	  as	  those	  of	  clone	  3.	  (B)	  RT	  PCR	  assay	  standard	  curve:	  the	  standard	  curve	  was	  derived	  from	  the	  logarithmic	  input	  template	  quantity	  (copies	  per	  
reaction)	  of	  consensus	  clone	  3	  in	  vitro	  transcript	  vs.	  the	  measured	  threshold	  cycle.	  Correlation	  coefficient	  of	  the	  curve	  0.997,	  slope	  −3.531.	  
3.1.2.	  Gag	  real-­‐time	  PCR	  assay	  performance	  on	  variant	  clones	  
The	  ability	  of	  the	  real-­‐time	  assay	  to	  detect	  variants	  within	  the	  viral	  stock	  was	  tested	  using	  serial	  dilutions	  of	  
plasmids	  carrying	  either	  consensus	  or	  variant	  primer	  and	  probe	  sequences.	  The	  complete	  dilution	  series	  of	  
all	   clones	  were	  amplified,	  with	  consensus	  clones	  3	  and	  11	  giving	   the	  same	  results	   (efficiency	  89.3%).	  The	  
amplification	   efficiency	   of	   variant	   clones	   1	   and	   6	   was	   somewhat	   lower	   (88.7%	   and	   84.6%	   respectively)	  
although	   the	   dynamic	   range	   was	   similar	   (Fig.	   2A),	   which	   caused	   a	   large	   underestimation	   of	   the	   copy	  
number	  of	  the	  viral	  variants	  especially	  at	  high	  copy	  numbers	  (Table	  2).	  
	  	  	  	  Table	  2.	  
	  3.1.3.	  Linear	  range	  of	  amplification	  of	  gag	  real-­‐time	  RT	  PCR	  assay	  
To	  determine	  the	  linear	  range	  of	  amplification	  for	  the	  RT	  PCR	  assay	  a	  10	  fold	  serial	  dilution	  of	  gag	  transcript	  
ranging	  from	  1	  ×	  106	  to	  10	  copies/reaction	  was	  examined.	  The	  amplification	  was	  linear	  over	  five	  orders	  of	  
magnitude	  (	  Fig.	  2B)	  with	  a	  lower	  detection	  limit	  of	  100	  RNA	  molecules	  per	  reaction.	  
3.1.4.	  Gag	  real-­‐time	  PCR	  vs.	  real-­‐time	  RT	  PCR	  assay	  performance	  
To	  evaluate	  the	  performance	  of	  the	  real-­‐time	  PCR	  in	  comparison	  with	  the	  real-­‐time	  RT	  PCR	  assay,	  DNA	  and	  
RNA	  were	  extracted	   from	  aliquots	  of	  an	  EV1	   infected	  ovine	   fibroblast	   cell	   culture,	  quantified	  and	  serially	  
diluted	  to	  10−6.	  The	  highest	  dilutions	  of	  DNA	  and	  RNA	  still	  yielding	  a	  positive	  signal	  in	  at	  least	  one	  replica	  
sample	  were	  1	  ×	  10−6	  and	  2	  ×	  10−5,	  corresponding	  to	  0.1	  pg	  of	  DNA	  and	  0.7	  pg	  of	  RNA,	  carrying	  4	  copies	  of	  
proviral	  DNA	  and	  139	  copies	  of	  viral	  RNA	  respectively	  (mean	  values).	  
3.2.	  Pol	  LUX	  real-­‐time	  PCR	  assay	  
Primer	  sequences	  selected	  with	  LUX	  Designer	  software	  were	  highly	  conserved:	  only	  1	  out	  of	  11	  clones	  had	  
multiple	  mutations,	  within	  the	  forward	  primer	  (ntd	  3403,	  3411,	  3413	  and	  3415).	  Amplicon	   length	  was	  77	  
bp.	  The	  assay	  was	  performed	  on	  serial	  dilutions	  of	  a	  consensus	  plasmid	  clone,	   ranging	   from	  1	  ×	  106	  to	  3	  
copies/reaction.	   The	   sensitivity	   of	   this	   assay	   was	   unsatisfactory	   with	   templates	   of	   less	   than	   100	   copies	  
because	  no	  good	  correlation	  was	   found	  between	  viral	   copy	  number	  and	   threshold	  cycle.	  Templates	  with	  
100,	  50	  and	  10	  copies	  had	  Ct	  values	  of	  44.06,	  45.66	  and	  45.36	  (mean	  values	  of	  six	  experiments).	  
3.3.	  Pol	  real-­‐time	  primers	  and	  probe	  
The	  consensus	  sequence	  of	  pol	  clones	  amplified	  from	  fibroblasts	  infected	  with	  EV1	  viral	  stock	  shared	  94%	  
identity	  with	  the	  published	  EV1	  sequence.	  The	  real-­‐time	  primer	  probe	  combination	  selected	  by	  best	  fit	  with	  
the	  consensus	  sequence	   (	  Table	  1),	  displayed	  higher	   interclonal	   sequence	  heterogeneity	   than	  gag,	  within	  
the	   probe	   and	   both	   primers	   (	   Fig.	   1A	   and	   B).	   Amplicon	   length	  was	   146	   bp.	  When	   the	   primers	   ability	   to	  
amplify	  the	  viral	  variants	  was	  tested	  by	  conventional	  PCR,	  3	  out	  of	  11	  clones	  (1,	  5	  and	  9),	  all	  carrying	  the	  
same	  three	  mismatches,	  within	  the	  reverse	  primer,	  escaped	  detection.	  
3.3.1.	  Pol	  dual	  labelled	  real-­‐time	  PCR	  assay	  
The	  real-­‐time	  pol	  assay	  amplified	  the	  complete	  dilution	  series	  of	  consensus	  plasmid	  clone	  3	  (1	  ×	  106	  to	  5	  
copies/reaction,	  reaction	  efficiency	  88.5%,	  slope	  −3.632),	  as	  well	  as	  all	  variant	  clones,	  with	  a	  detection	  limit	  
of	   10	   copies.	   However,	   templates	   carrying	   variant	   primer	   and	   probe	   sequences	   were	   not	   efficiently	  
amplified:	  as	  a	   result	   the	  number	  of	   template	  molecules	  was	  underestimated	   in	  variant	   clones	   (data	  not	  
shown).	  
3.4.	  Evaluation	  of	  specificity	  and	  sensitivity	  of	  gag	  and	  pol	  dual	  labelled	  probe	  PCR	  assays:	  analysis	  of	  PBMC	  
samples	  
A	  panel	  of	  204	  DNAs	  extracted	  from	  PBMCs	  of	  68	  sheep	  infected	  experimentally	  and	  222	  DNAs	  from	  PBMCs	  
of	   74	   uninfected	   sheep	   (Niesalla	   et	   al.,	   2009)	  was	   analyzed	  with	   both	   dual	   labelled	   probe	   real-­‐time	   PCR	  
assays.	  A	  set	  volume	  of	  5	  μl	  of	  DNA	  was	  used	  as	  template	  irrespective	  of	  DNA	  concentration	  of	  the	  samples.	  
In	   some	   cases	   the	   amount	   of	  DNA	  per	   reaction	   exceeded	   the	  maximum	   suggested	   by	   the	  manufacturer	  
(500	  ng).	  However,	   experiments	  with	   increasing	   amounts	   of	  DNA	   (200	  ng	   to	   2.5	  μg)	   showed	  no	   adverse	  
effect	   on	   assay	   performance	   (data	   not	   shown).	   Neither	   gag	   nor	   pol	   PCRs	   generated	   any	   false	   positive	  
results	  with	  the	  known	  uninfected	  samples,	  showing	  100%	  specificity.	  The	  average	  viral	  loads	  detected	  with	  
gag	   assay	   ranged	   from	   1	   to	   1009	   copies	   per	  microgram	  of	   DNA,	   and	  with	   pol	   assay	   from	   1	   to	   432.	   The	  
majority	  of	  samples	  had	   loads	  below	  100	  copies.	   In	  most	  cases,	  the	  pol	  assay	  gave	  results	  showing	   lower	  
numbers	   of	   viral	   molecules	   than	   the	   gag	   assay	   and	   generated	   some	   false	   negative	   results,	   when	   the	  
number	  of	  viral	  genomes	  was	   low	   (	  Fig.	  3)	  The	  gag	  assay	  detected	  185	  and	   the	  pol	  assay	  172	  out	  of	  204	  
infected	   samples	   (	   Table	   3).	   The	   sensitivity	   values	  of	   the	   gag	   and	  pol	   real-­‐time	  PCRs	  were	  91%	  and	  84%	  
respectively.	  
	  
	  	  	  	  Fig.	  3.	  	  
	  	  	  	  Dot	  plot	  comparison	  of	  gag	  and	  pol	   input	  DNA	  (copy	  number/microgram).	  A	  total	  of	  222	  DNA	  samples	   from	  68	  sheep	  experimentally	   infected	  
with	  EV1	  were	  analysed.	  
	  




Real-­‐time	  PCR	  technology	  represents	  the	  tool	  of	  choice	  to	  detect	  and	  quantify	  viral	  genomes	  or	  transcripts.	  
Recently,	  real-­‐time	  PCR	  and	  real-­‐time	  RT	  PCR	  assays	  have	  been	  developed	  for	  SRLVs,	  for	  diverse	  purposes,	  
such	  as	  the	  analysis	  of	  viral	  transcription	  pattern	  in	  infected	  cell	  cultures	  (Gudmundsson	  et	  al.,	  2003),	  the	  
study	  of	  viral	  persistence	  in	  long	  term	  infected	  goats	  (Ravazzolo	  et	  al.,	  2006)	  and	  the	  characterization	  of	  the	  
growth	  properties	  of	  viral	  strains	  (Barros	  et	  al.,	  2004).	  In	  these	  experiments,	  either	  a	  single	  viral	  isolate	  or	  a	  
SRLV	   molecular	   clone	   was	   used	   for	   the	   infections.	   Primers	   and	   probes	   were	   designed	   based	   on	   the	  
sequence	  of	  the	  isolate	  or	  the	  molecular	  clone	  utilized	  throughout	  the	  study,	  to	  amplify	  env	  (	  Ravazzolo	  et	  
al.,	   2006),	   gag	   (	   Barros	   et	   al.,	   2004)	   or	   each	   of	   the	   viral	   transcripts	   (	   Gudmundsson	   et	   al.,	   2003).	   This	  
approach	   resulted	   in	   robust	   PCRs	   linear	   over	   6	   or	   7	   orders	   of	   magnitude	   which	   were	   able	   to	   detect	  
templates	  carrying	  respectively	  less	  than	  10	  copies	  and	  60	  copies	  of	  viral	  molecules	  (	  Gudmundsson	  et	  al.,	  
2003	   and	   Ravazzolo	   et	   al.,	   2006).	   Few	   reports	   describe	   real-­‐time	   protocols	   designed	   for	   diagnostic	   use.	  
Given	  the	  high	  degree	  of	  genetic	  heterogeneity	  which	  characterizes	  the	  SRLVs	  (	  Zanoni,	  1998),	  diagnostic	  
assays	   were	   based	   on	   conserved	   sequences	   of	   the	   LTR,	   gag	   and	   env	   regions	   (	   Brinkhof	   et	   al.,	   2008,	  
Herrmann-­‐Hoesing	   et	   al.,	   2007	   and	   Peterson	   et	   al.,	   2008).	   Samples	  were	   simply	   classified	   as	   positive	   or	  
negative	   by	   Brinkhof	   and	   by	   Peterson,	   who	   did	   not	   report	   quantitative	   data.	   Herrmann	   Hoesing	   and	  
colleagues	   described	   identification	   of	   samples	   with	   proviral	   loads	   ranging	   from	   1	   to	   6	   ×	   104	   copies	   per	  
microgram	  of	  DNA	  in	  sheep	  infected	  naturally.	  However,	  the	  efficiency	  of	  the	  assay	  was	  not	  reported,	  and	  
the	   copy	   number	   of	   the	   reference	   gene,	   glyceraldehyde	   3-­‐phosphate	   dehydrogenase	   (gapdh),	   showed	  
tenfold	  variations	  among	  samples.	  The	  present	  report	  describes	  the	  development	  of	  real-­‐time	  PCR	  assays	  
to	  measure	  the	  viral	  load	  of	  the	  British	  VMV	  EV1	  strain.	  This	  strain	  has	  been	  and	  is	  currently	  the	  object	  of	  
extensive	   investigations	   focusing	   on	   diverse	   aspects	   of	   lentiviral	   infections.	   Several	   in	   vivo	   and	   in	   vitro	  
models	   of	   infection	   with	   EV1	   have	   been	   established	   over	   the	   years,	   where	   the	   viral	   sequences	   were	  
detected	   mostly	   by	   nested	   PCR,	   allowing	   only	   approximate	   quantitative	   evaluations	   (	   Bird	   et	   al.,	   1993,	  
Niesalla	  et	  al.,	  2008	  and	  Ryan	  et	  al.,	  2000).	  A	  QC	  PCR	  was	  developed	  to	  determine	  accurately	  and	  compare	  
the	  EV1	  viral	  load	  in	  peripheral	  blood	  monocytes	  and	  in	  alveolar	  macrophages	  of	  infected	  sheep	  (	  Zhang	  et	  
al.,	   2000).	  However	   this	   technique	   is	   quite	   laborious	   and	  not	   suited	   for	   the	  analysis	   of	   large	  numbers	  of	  
samples.	  In	  the	  present	  study,	  real-­‐time	  assays	  were	  developed	  for	  two	  genes,	  gag	  and	  pol,	  to	  compare	  and	  
confirm	   the	   results	   obtained	   with	   each	   individual	   gene.	   Based	   on	   the	   observation	   that	   the	   genetic	  
variability	   of	   lentiviruses	   occurs	   not	   only	   among	   isolates	   but	   also	   within	   a	   single	   isolate	   during	   in	   vitro	  
cultivation	  or	  during	  the	  course	  of	  the	  infection	  (	  Balfe	  et	  al.,	  1990,	  Pisoni	  et	  al.,	  2007,	  Sargan	  et	  al.,	  1991	  
and	  Sargan	  et	  al.,	  1995),	  real-­‐time	  amplicons	  were	  designed	  based	  on	  the	  consensus	  sequences	  of	  several	  
gag	  and	  pol	  clones	  representative	  of	  EV1	  stock	  variants.	  Both	  gag	  and	  pol	  dual	   labelled	  probe	  PCRs	  had	  a	  
sensitivity	   sufficient	   to	  amplify	   the	  most	  diluted	   standard	   templates	   (3	   copies/reaction).	   The	  presence	  of	  
mutations	  within	  primers	  and	  probe	  sequences	  reduced	  the	  sensitivity	  of	  the	  PCR	  assays,	  as	  demonstrated	  
when	   individual	   clonal	   variants	   were	   used	   as	   templates.	   Although	   the	   efficiency	   values	   with	   mutant	  
plasmids	   did	   not	   differ	   dramatically	   from	   the	   efficiency	   of	   the	   consensus	   plasmid	   used	   to	   generate	   the	  
standard	  curve,	  the	  resulting	  copy	  numbers	  of	  mutant	  templates	  were	  greatly	  underestimated,	  especially	  
for	  high	  copy	  samples.	  In	  vivo,	  however,	  the	  situation	  is	  more	  complex	  because	  infected	  samples	  are	  likely	  
to	  contain	  a	  heterogeneous	  population	  of	  viral	  variants	  represented	  differentially	  and	  the	  overall	  efficiency	  
of	  the	  assay	  will	  reflect	  this	  genetic	  complexity.	  The	  performances	  of	  the	  two	  PCRs	  in	  vivo	  were	  evaluated	  
and	  compared	  on	  a	  large	  panel	  of	  DNAs	  extracted	  from	  PBMCs	  of	  sheep	  infected	  experimentally	  with	  EV1,	  
at	  increasing	  time	  intervals	  until	  3	  months	  p.i.	  The	  results	  showed	  that	  the	  pol	  assay	  detected	  in	  most	  cases	  
lower	  numbers	  of	  viral	  molecules	  than	  gag	  and	  failed	  to	  detect	  some	  infected	  samples	  which	  were	  low	  copy	  
positive	   with	   the	   gag	   assay,	   probably	   due	   to	   the	   higher	   sequence	   heterogeneity	   of	   pol.	   The	   viral	   loads	  
detected	  with	  gag	  and	  with	  pol	  assays	  were	  in	  the	  same	  range	  as	  those	  detected	  with	  env	  assays	  in	  PBMCs	  
of	  long	  term	  experimentally	  infected	  goats	  (	  Ravazzolo	  et	  al.,	  2006)	  and	  long	  term	  naturally	  infected	  sheep	  (	  
Herrmann-­‐Hoesing	  et	  al.,	  2007).	  The	  gag	  real-­‐time	  RT	  PCR	  showed	  linearity	  over	  5	  orders	  of	  magnitude	  (106	  
to	  100	  copies	  of	  template)	  and	  the	  gag	  real-­‐time	  PCR	  over	  6	  orders	  (106	  to	  10	  copies	  of	  template),	  when	  
gag	  transcript	  or	  plasmid	  DNA	  were	  used	  as	  templates.	  This	  difference	  was	  not	  expected	  to	  result	  in	  a	  lower	  
performance	  of	  the	  RT	  PCR	  compared	  to	  the	  PCR	  in	  cells	  and	  tissues	  permissive	  for	  virus	  replication,	  which	  
are	   likely	   to	   contain	   higher	   numbers	   of	   viral	   transcripts	   than	   proviral	   genomes.	   This	   was	   shown	   by	  
Ravazzolo	  et	  al.	  (2006)	  who	  quantified	  mRNA	  and	  proviral	  DNA	  in	  several	  goat	  tissues	  and	  is	  confirmed	  in	  
this	  study	  with	  the	  quantitation	  of	  RNA	  and	  DNA	  extracted	  from	  the	  same	  cell	  culture	  infected	  in	  vitro	  with	  
EV1	  stock.	  In	  conclusion,	  the	  real-­‐time	  assays	  developed	  in	  this	  study,	  particularly	  the	  gag	  assay,	  provide	  a	  
sensitive	  tool	  which	  can	  be	  used	  to	  quantify	  the	  viral	   load	   in	  experimental	   infections.	  Given	  the	  evidence	  
that	  mutations	  within	  primer	  and	  probe	  sequences	  affect	   to	  some	  extent	  the	  performance	  of	   the	  assays,	  
and	   depending	   on	   the	   nature	   of	   the	   investigation,	   the	   use	   of	   a	   molecular	   clone	   of	   the	   virus	   could	   be	  
beneficial	  in	  reducing	  loss	  of	  efficiency.	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